---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-028789"
form_type: "8-K"
ticker: "JUNS"
cik: "0001679628"
company_name: "JUPITER NEUROSCIENCES, INC."
filed_at: "2025-12-22T23:59:59+00:00"
generated_at: "2026-05-16T12:25:38.429773+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Jupiter Neurosciences shareholders approve 4x increase in authorized shares to 500M and new equity plan

## Summary
- Authorized common stock increased from 125M to 500M shares via amendment approved by 20.2M votes for, 4.5M against.
- 2025 Equity Incentive Plan approved, authorizing 5,250,000 shares for future equity awards.
- Potential issuance of up to $20M of stock to Yorkville under SEPA (including convertible notes) approved with 20.1M for, 24.7K against.
- Seven director nominees elected; Christer Rosén, Marshall Hayward, Alison Silva, Nicholas Hemmerly, Julie Kampf, Allison Brady, Holger Weis.
- Cherry Bekaert ratified as independent auditor for FY2025 with 24.6M votes for.

## SEC filing metadata
- accession: 0001493152-25-028789
- form_type: 8-K
- ticker: JUNS
- cik: 0001679628
- company_name: JUPITER NEUROSCIENCES, INC.
- filed_at: 2025-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02, 5.07, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1679628/000149315225028789/0001493152-25-028789-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1679628/000149315225028789/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-028789
- JSON: https://secwatch.observer/filing/0001493152-25-028789.json
- Plain text: https://secwatch.observer/filing/0001493152-25-028789.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.